IN8bio
INAB
24 hedge funds and large institutions have $7.72M invested in IN8bio in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 6 closing their positions.
275% more capital invested
Capital invested by funds: $2.06M → $7.72M (+$5.66M)
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
0.84% more ownership
Funds ownership: 0.54% → 1.38% (+0.84%)
8% less funds holding
Funds holding: 26 → 24 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.67M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.35M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.32M |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$55.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$224K |
| 2 |
6CM
683 Capital Management
New York
|
-$176K |
| 3 |
TCBWMS
Texas Capital Bank Wealth Management Services
Dallas,
Texas
|
-$21.2K |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$17.3K |
| 5 |
VF
Virtu Financial
New York
|
-$9.02K |
INAB Hedge Fund Activity: Q4 2024 in Review
24 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q4 2024, worth a combined $7.72M — up 275% from $2.06M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of INAB and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 11 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $1.67M. The largest seller was Ensign Peak Advisors, exiting entirely with an estimated $224K sold.
- 24 institutional investors held IN8bio (INAB) as of Q4 2024, down from 26 in Q3 2024.
- Funds reported $7.72M of IN8bio stock for Q4 2024, up 275% quarter-over-quarter.
- 4 funds opened new IN8bio positions in Q4 2024 and 6 closed out, a net change of -2 holders.
- The largest IN8bio buyer in Q4 2024 was Franklin Resources, an estimated $1.67M added.
- The largest IN8bio seller in Q4 2024 was Ensign Peak Advisors, an estimated $224K sold.
Based on aggregated 13F filings for Q4 2024.